Medpace Voice

IDWeek 2025 marked a pivotal moment in the evolution of infectious diseases (ID) research and pharmaceutical innovation. Beyond its traditional...

Menopause remains one of the most underrepresented areas in clinical research. Yet this life stage, marked by profound physiological transitions and long-term health implication, presents…

With global recognition of obesity as a complex, chronic disease impacting over one billion people, advancements in obesity clinical development...

With the launch of a newly built, state-of-the-art clinical pharmacology unit, Medpace strengthens its position as a strategic early phase...

Representatives from Medpace’s medical and operational teams engaged in critical discussions around trial innovation, therapeutic advances, and evolving standards of...

Medpace Medical and Clinical Operations Experts Share Key Insights from the ENCALS Meeting

Radiopharmaceuticals are reshaping oncology trials through integrated imaging, dosimetry, and therapeutic precision. Following SNMMI, Medpace experts share considerations for biopharma Sponsors navigating the scientific, operational,…

Digestive Disease Week® is one of the largest congresses in the US in the fields of gastroenterology, hepatology and endoscopy....

Medpace oncology experts examine the clinical and operational concepts driving the next phase of oncology development presented at 2025 ASCO.

As cardiovascular clinical trials evolve, imaging biomarkers have become essential tools for enriching patient populations, evaluating therapeutic response and accelerating...